Apo-ai/aii peptide derivatives

Details for Australian Patent Application No. 2001257173 (hide)

Owner Amgen Inc.

Inventors Kohno, Tadahiko

Agent Shelston IP

Pub. Number AU-B-2001257173

PCT Pub. Number WO01/81376

Priority 60198920 21.04.00 US

Filing date 23 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 22 September 2005

International Classifications

C07K 014/00 Peptides having more than 20 amino acids

Event Publications

22 September 2005 Application Accepted

  Published as AU-B-2001257173

19 January 2006 Standard Patent Sealed

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001257174-Integrin/adhesion antagonists

2001257172